Tuesday, March 31, 2020 - Individuals that are HIV positive have been taking Truvada for years not knowing that the drug carries the potential to cause kidney failure and bone density loss. The degree of severity of the harm and the percentage of patients experiencing injuries have come into focus recently as many individuals started taking Truvada for pre-exposure prophylactic purposes in addition to their sexual partners taking the drug to help slow the progression of AIDS and to manage the disease's symptoms. LGBTQ activist groups have spoken out loudly and objected to attorney ads on Facebook that sought to sign up clients that had suffered Truvada's dangerous side effects for a class action lawsuit against Gilead for keeping a safer drug (Descovy) off of the market until Truvada's patent expired this year. The health advocate group's objections stemmed from the fact that the usage of the drug had changed from AIDS management to prevention of transmission between partners, and statistics are not as of yet available for the latter group. Attorney ads were thought to blur the distinction between the two groups and to effectively scare off those seeking the drug preventatively to have safer sexual relations. Truvada lawsuits represented by top national attorneys offer a free no obligation consultation before filing a claim.
Ads on Facebook and Twitter by lawyers looking for clients to join class-action lawsuits are seeking Truvada users that have been "harmed or injured" and that may imply that the drug has unknown side effects that a preponderance of users have suffered from. Most ads do not temper their solicitation with facts stating a low percentage that has side effects. One Twitter ad states: "Truvada linked to bone density and kidney side effects" without clarifying that these side effects have been reported by HIV positive individuals with previously weakened immune systems, not by PrEP users that are healthy and HIV negative. The ads further state that "Anyone who has experienced severe negative side effects due to the medication called Truvada may be eligible for significant compensation." Gilead, the maker of Truvada and Descovy face hundreds of lawsuits from individuals that took Truvada regularly and for years and developed kidney disease and failure or osteoporosis the premature weakening of one's bone density. It is alleged that Gilead deliberately withheld Truvada's replacement Descovy from the market for financial considerations despite knowing that the drug was safer.
Medical experts have taken exception to Gilead's claim that Descovy is safer than Truvada, however, and are telling their patients that Descovy may be marginally safer than the generic alternative now on the market but not worth the more than double price tag of the generic brand. Aids Info at the National Institute of Health classifies Truvada first as a medication for HIV positive individuals: "Truvada is a prescription medicine approved by the U.S. Food and Drug Administration (FDA)... to treat HIV infection in adults and children who weigh at least 37 lb (17 kg). Truvada for HIV treatment is always used in combination with other HIV medicines. HIV medicines canít cure HIV/AIDS, but taking HIV medicines every day helps people with HIV live longer, healthier lives and reduces the risk of HIV transmission."
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.